Serological evaluation of soluble CD44 in renal cancer

Japanese Journal of Cancer Research

Volumn 87, Issue 11, 1996, Pages 1191-1194

  Kan, Masaharu ^a,b   Kanayama, Hiro Omi ^a   Naruo, Seiichi ^a   Tsuji, Masahito ^a   Kojima, Keiji ^a   Kurokawa, Yasushi ^a   Kagawa, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Renal cancer; Soluble CD44

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ANTIGENIC VARIATION; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; HUMAN; KIDNEY CANCER; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY;

EID: 0029969878     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03131.x     Document Type: Article

References (20)

1. Huet, S., Groux, H., Caillou, B., Valentin, H., Prieur, A. M. and Bernard, A. CD44 contributes to T cell activation. J. Immunol., 143, 798-803 (1989).
2. Shimizu, Y., van Seventer, G. A., Siraganian, R., Wahl, L. and Shaw, S. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol., 143, 2457-2463 (1989).
3. St. John, T., Meyer, J., Iderza, R. and Gallatin, W. M. Expression of CD44 confers a new adhesive phenotype on transfected cell. Cell, 60, 45-52 (1990).
4. Carner, W. G. and Warner, E. A. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J. Biol. Chem., 263, 4193-4201 (1988).
5. Jackson, D. G., Buckley, J. and Bell, J. I. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J. Biol. Chem., 267, 4734-4739 (1992).
6. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U. and Bell, J. I. Genetic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89, 12160-12164 (1992).
7. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Hauβmann, I., Siegfried, M., Wenzel, A., Ponta, H. and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
8. Lucas, M. G., Green, A. M. and Telen, M. J. Characterization of the serum In (Lu)-related antigen: identification of a serum protein related to erythrocyte p80. Blood, 73, 596-600 (1989).
9. Haynes, B. F., Hale, L. P., Patton, K. L., Martin, M. E. and McCallum, R. M. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Arthritis Rheum., 34, 1434-1443 (1991).
10. Guo, Y. J., Liu, G., Wang, X., Jin, D., Wu, M., Ma, J. and Sy, M. S. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res., 54, 422-426 (1994).
11. deKarnion, J. B. and Belldegrun, A. "Renal tumors, Campbell's Urology," 6th Ed., pp. 1053-1093 (1992). W. B. Saunders, Philadelphia.
12. Kan, M., Aki, M., Akiyama, K., Naruo, S., Kanayama, H. and Kagawa, S. High-level expression of the CD44 variant sharing exon v10 in renal cancer. Jpn. J. Cancer Res., 86, 847-853 (1995).
13. Hamao, T., Kanayama, H., Kan, M., Takigawa, H. and Kagawa, S. Serum levels and gene expressions of interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in human renal cell carcinomas. Jpn. J. Urol., 85, 563-570 (1994).
14. Ristamäki, B. R., Joensuu, H., Salmi, M. and Jalkanen, S. Serum CD44 in malignant lymphoma: an association with treatment response. Blood, 84, 238-243 (1994).
15. Kainz, C., Tempfer, C., Winkler, S., Sliutz, G., Koelbl, H. and Reinthaller, A. Serum CD44 splice variants in cervical cancer patients. Cancer Lett., 90, 231-234 (1995).
16. Sliutz, G., Tempfer, C., Winkler, S., Kohlberger, P., Reinthaller, A. and Kainz, Ch. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br. J. Cancer, 72, 1494-1497 (1995).
17. Bazil, V. and Horejsi, V. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody stimulating the effect of a natural receptor ligand. J. Immunol. 149, 747-753 (1992).
18. Satomi, Y. A clinical study on the prognosis of renal cell carcinoma - with reference to factors on the part of host -. Jpn. J. Urol., 64, 195-216 (1973).
19. Tsukamoto, T., Kumamoto, Y., Miyao, N., Masumori, N., Takahashi, A. and Yanase, M. Interleukin-6 in renal cell carcinoma. J. Urol., 148, 1778-1782 (1992).
20. Kanayama, H., Kan, M., Aki, M. and Kagawa, S. Expression of CD44 variant form in human renal cell carcinoma. Jpn. J. Clin. Med., 53, 1710-1715 (1995).